HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy

Prediction of breast cancer response to Neoadjuvant Chemotherapy (NACT) is an urgent need to promptly direct non-responder patients to alternative therapies. Infiltrating T lymphocytes, namely cytotoxic T lymphocytes (CTLs) have been appointed as predictors of response. However, cancer cells have th...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraiva, Diana P., Jacinto, António, Borralho, Paula, Braga, Sofia, Cabral, M. Guadalupe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282034/
https://www.ncbi.nlm.nih.gov/pubmed/30555458
http://dx.doi.org/10.3389/fimmu.2018.02605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282034/
https://www.ncbi.nlm.nih.gov/pubmed/30555458
http://dx.doi.org/10.3389/fimmu.2018.02605

Ejemplares similares